Brain Imaging Study in Subjects With Alzheimer Disease in Comparison to Healthy Subjects

Summary

The underlying goal of this study is to assess 123-I MNI-168 SPECT imaging as a tool to detect ß-amyloid deposition in the brain of Alzheimer's Disease (AD) research participants and similarly aged and gender matched healthy subjects.

Timeline

Start

2009-01

Primary completion

2010-12

Completion

2010-12

Outcome

Outcome not reported

Stopped: “Assessment of data shows inadequate brain uptake, suggesting the tracer is inadequate as an imaging biomarker of brain amyloid.”

Drugs

Indications